Issue Archive
Table of Contents
Inside Blood
Perspectives
International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation
Clinical Trials & Observations
Review Articles
How I Treat
Hematopoiesis and Stem Cells
STAT3-dependent IL-21 production from T helper cells regulates hematopoietic progenitor cell homeostasis
Brief Report
Immunobiology
Heat-shock protein 90 inhibition in autoimmunity to type VII collagen: evidence that nonmalignant plasma cells are not therapeutic targets
Lymphoid Neoplasia
HIV-1–related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes
Clinical Trials & Observations
Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC
Clinical Trials & Observations
Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion
Combinatorial effects of microRNAs to suppress the Myc oncogenic pathway
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Myeloid Neoplasia
Long-term risk for subsequent leukemia after treatment for childhood cancer: a report from the Childhood Cancer Survivor Study
Brief Report
Platelets and Thrombopoiesis
Red Cells, Iron, and Erythropoiesis
Thrombosis and Hemostasis
The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A
Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom
Brief Report
Transplantation
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius
Clinical Trials & Observations
Vascular Biology
-
Cover Image
Cover Image
The cover image shows how maternal IgG antibodies inhibit B-cell responses by cross-linking the B-cell receptor (BCR; membrane-bound Ig in green in the center) with the inhibitory Fc receptor (FcγRIIB; in brown on the left) through a measles vaccine virus–IgG complex. This inhibition can be partially overcome by cross-linking the B-cell receptor with the stimulatory complement receptor 2 (CD21/CD19/CD81/Leu-13; in green and blue to the right) through a measles vaccine virus–IgM (pentameter in purple)–complement C3d protein (orange) complex. (Illustration by Tim Vojt, Medical Illustrator, The Ohio State University.) See the full article by Kim et al on page 6143.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals